MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 56 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 2,435,806 | $1,721,871 | 0.88% |
| Monaco Asset Management SAM | 1,316,245 | $930,454 | 0.28% |
| DAFNA Capital Management LLC | 1,096,513 | $775,125 | 0.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $5,205,921 | 0.22% |
| Clearline Capital LP | 2,052,709 | $1,451,060 | 0.22% |
| Rubric Capital Management LP | 10,366,120 | $7,327,810 | 0.19% |
| Orbimed Advisors | 7,747,891 | $5,476,984 | 0.11% |
| Rock Springs Capital Management LP | 6,244,897 | $4,414,518 | 0.10% |
| 683 Capital Management, LLC | 2,000,000 | $1,413,801 | 0.10% |
| Privium Fund Management (UK) Ltd | 177,200 | $131,128 | 0.10% |